Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Direct-to-consumer promotion: an industry perspective

W L Pines1

  • 1Regulatory Affairs, APCO Associates, Washington, DC 20036, USA.

Clinical Therapeutics
|January 23, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Research and publicity.

Pharmaceutical research·2013
Same author

A history and perspective on direct-to-consumer promotion.

Food and drug law journal·2002
Same author

Direct-to-consumer advertising.

The Annals of pharmacotherapy·2000
Same author

Major issues in marketing regulation.

Food and drug law journal·1997
Same author

New challenges for medical product promotion and its regulation.

Food and drug law journal·1997
Same author

The federal regulation of prescription drug advertising and promotion.

JAMA·1990
Same journal

Early Feasibility Studies in Europe: A Multisite Qualitative Study of Operational Challenges and Site Selection Determinants at 6 University Hospitals.

Clinical therapeutics·2026
Same journal

Safety of Celecoxib in Elderly Patients With Osteoarthritis: A Real-World Analysis Based on the FAERS Database.

Clinical therapeutics·2026
Same journal

Reimagining Representation Across the Clinical Research Ecosystem: Part II of a Specialty Update on Advancing Diversity, Racial Equity, and Inclusion in Clinical Research.

Clinical therapeutics·2026
Same journal

Combined Effects of Nicorandil and Enhanced External Counterpulsation on Coronary Microcirculation and Exercise Capacity in Patients With Coronary Slow Flow Phenomenon: A Randomized, Controlled, 3-Arm Trial.

Clinical therapeutics·2026
Same journal

Phase 1 Study Evaluating Gefurulimab Pharmacokinetics and Safety Following Delivery Via Autoinjector or Prefilled Syringe With Needle Safety Device in Healthy Adults.

Clinical therapeutics·2026
Same journal

Evaluating Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Associated With Newer Antiseizure Medications Using FAERS and JADER Combined With Bioinformatics Exploration.

Clinical therapeutics·2026
See all related articles

Direct-to-consumer (DTC) advertising for prescription drugs offers significant consumer benefits. Further research is essential to address remaining questions and optimize this healthcare trend.

Area of Science:

  • Health economics
  • Pharmaceutical marketing
  • Healthcare policy

Background:

  • Direct-to-consumer (DTC) advertising of prescription medicines is a growing trend.
  • This form of marketing influences patient-provider interactions and healthcare decisions.
  • Understanding the implications of DTC advertising is crucial for healthcare stakeholders.

Purpose of the Study:

  • To explore the potential benefits of DTC advertising for consumers.
  • To identify key questions requiring further investigation in this area.
  • To provide a balanced perspective on the role of DTC advertising in healthcare.

Main Methods:

  • Literature review of existing studies on DTC advertising.
  • Analysis of consumer perception and engagement with DTC campaigns.

Related Experiment Videos

  • Examination of regulatory frameworks governing pharmaceutical promotion.

    • Main Results:

    • DTC advertising has the potential to empower consumers with health information.
    • Increased patient awareness of treatment options can lead to better health outcomes.
    • However, potential risks and ethical considerations require careful evaluation.

    Conclusions:

    • DTC advertising presents a significant opportunity to enhance consumer engagement in healthcare.
    • Continued research is necessary to fully understand and mitigate potential drawbacks.
    • Strategic implementation can maximize the benefits of DTC advertising for public health.